Capital World Investors Gilead Sciences, Inc. Transaction History

Capital World Investors

  • $633 Billion
  • Q4 2024

A detailed history of Capital World Investors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital World Investors holds 71,706,362 shares of GILD stock, worth $8 Billion. This represents 1.05% of its overall portfolio holdings.

Number of Shares
71,706,362
Previous 76,548,928 6.33%
Holding current value
$8 Billion
Previous $6.42 Billion 3.23%
% of portfolio
1.05%
Previous 1.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$83.95 - $97.9 $407 Million - $474 Million
-4,842,566 Reduced 6.33%
71,706,362 $6.62 Billion
Q3 2024

Nov 13, 2024
BUY
$66.59 - $83.99 $19.9 Million - $25.1 Million
299,109 Added 0.39%
76,548,928 $6.42 Billion
Q2 2024

Aug 13, 2024
SELL
$63.15 - $72.88 $521 Million - $601 Million
-8,247,585 Reduced 9.76%
76,249,819 $5.23 Billion
Q1 2024

May 14, 2024
BUY
$71.58 - $87.29 $81.1 Million - $98.9 Million
1,133,281 Added 1.36%
84,497,404 $6.19 Billion
Q4 2023

Feb 13, 2024
BUY
$73.27 - $83.09 $120 Million - $136 Million
1,642,736 Added 2.01%
83,364,123 $6.75 Billion
Q3 2023

Nov 13, 2023
BUY
$73.94 - $80.67 $58.6 Million - $63.9 Million
792,071 Added 0.98%
81,721,387 $6.12 Billion
Q2 2023

Aug 11, 2023
BUY
$76.01 - $86.7 $337 Million - $384 Million
4,429,076 Added 5.79%
80,929,316 $6.24 Billion
Q1 2023

May 15, 2023
BUY
$77.31 - $88.08 $588 Million - $670 Million
7,607,268 Added 11.04%
76,500,240 $6.35 Billion
Q4 2022

Feb 14, 2023
BUY
$62.32 - $89.47 $694 Million - $996 Million
11,130,228 Added 19.27%
68,892,972 $5.91 Billion
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $292 Million - $333 Million
4,903,276 Added 9.28%
57,762,744 $3.56 Billion
Q2 2022

Aug 15, 2022
BUY
$57.72 - $65.01 $194 Million - $218 Million
3,357,616 Added 6.78%
52,859,468 $3.27 Billion
Q1 2022

May 16, 2022
BUY
$57.92 - $72.58 $395 Million - $495 Million
6,820,228 Added 15.98%
49,501,852 $2.94 Billion
Q4 2021

Feb 14, 2022
BUY
$64.88 - $73.64 $370 Million - $420 Million
5,705,315 Added 15.43%
42,681,624 $3.1 Billion
Q3 2021

Nov 15, 2021
BUY
$67.69 - $73.03 $66.9 Million - $72.2 Million
988,974 Added 2.75%
36,976,309 $2.58 Billion
Q2 2021

Aug 16, 2021
BUY
$63.47 - $69.35 $57.4 Million - $62.7 Million
903,841 Added 2.58%
35,987,335 $2.48 Billion
Q1 2021

May 14, 2021
SELL
$60.0 - $68.46 $207 Million - $236 Million
-3,451,094 Reduced 8.96%
35,083,494 $2.27 Billion
Q4 2020

Feb 12, 2021
SELL
$56.65 - $64.55 $45.8 Million - $52.1 Million
-807,861 Reduced 2.05%
38,534,588 $2.24 Billion
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $258 Million - $325 Million
-4,161,381 Reduced 9.57%
39,342,449 $2.49 Billion
Q2 2020

Aug 14, 2020
SELL
$72.34 - $84.0 $205 Million - $238 Million
-2,827,488 Reduced 6.1%
43,503,830 $3.35 Billion
Q1 2020

May 15, 2020
BUY
$62.63 - $80.22 $1.6 Billion - $2.05 Billion
25,555,467 Added 123.01%
46,331,318 $3.46 Billion
Q4 2019

Feb 18, 2020
SELL
$61.62 - $67.78 $27.9 Million - $30.7 Million
-452,643 Reduced 2.13%
20,775,851 $1.35 Billion
Q3 2019

Nov 14, 2019
SELL
$62.51 - $69.0 $31.1 Million - $34.3 Million
-497,087 Reduced 2.29%
21,228,494 $1.35 Billion
Q2 2019

Aug 14, 2019
BUY
$61.87 - $69.38 $339 Million - $381 Million
5,485,081 Added 33.77%
21,725,581 $1.47 Billion
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $76.2 Million - $85.3 Million
1,217,836 Added 8.11%
16,240,500 $1.06 Billion
Q4 2018

Feb 14, 2019
BUY
$60.54 - $79.0 $107 Million - $140 Million
1,766,423 Added 13.33%
15,022,664 $940 Million
Q3 2018

Nov 14, 2018
BUY
$71.28 - $78.92 $93.9 Million - $104 Million
1,317,178 Added 11.03%
13,256,241 $1.02 Billion
Q2 2018

Aug 14, 2018
SELL
$64.88 - $75.68 $56.2 Million - $65.6 Million
-866,937 Reduced 6.77%
11,939,063 $846 Million
Q1 2018

May 15, 2018
BUY
$72.84 - $88.8 $59.1 Million - $72.1 Million
812,000 Added 6.77%
12,806,000 $965 Million
Q4 2017

Feb 14, 2018
BUY
$71.15 - $83.52 $495 Million - $581 Million
6,961,400 Added 138.33%
11,994,000 $859 Million
Q3 2017

Nov 14, 2017
BUY
$72.11 - $85.47 $363 Million - $430 Million
5,032,600
5,032,600 $408 Million

Others Institutions Holding GILD

# of Institutions
2,092
Shares Held
1.02B
Call Options Held
8.73M
Put Options Held
9.63M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $140B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email